全文获取类型
收费全文 | 86300篇 |
免费 | 6199篇 |
国内免费 | 447篇 |
专业分类
耳鼻咽喉 | 943篇 |
儿科学 | 2375篇 |
妇产科学 | 2151篇 |
基础医学 | 10507篇 |
口腔科学 | 1918篇 |
临床医学 | 8945篇 |
内科学 | 19100篇 |
皮肤病学 | 1339篇 |
神经病学 | 7055篇 |
特种医学 | 2688篇 |
外国民族医学 | 2篇 |
外科学 | 12979篇 |
综合类 | 1348篇 |
现状与发展 | 1篇 |
一般理论 | 134篇 |
预防医学 | 7267篇 |
眼科学 | 2332篇 |
药学 | 6130篇 |
4篇 | |
中国医学 | 181篇 |
肿瘤学 | 5547篇 |
出版年
2023年 | 488篇 |
2022年 | 779篇 |
2021年 | 1933篇 |
2020年 | 1210篇 |
2019年 | 1624篇 |
2018年 | 1924篇 |
2017年 | 1363篇 |
2016年 | 1564篇 |
2015年 | 1728篇 |
2014年 | 2551篇 |
2013年 | 3890篇 |
2012年 | 5346篇 |
2011年 | 5723篇 |
2010年 | 3209篇 |
2009年 | 3001篇 |
2008年 | 5286篇 |
2007年 | 5643篇 |
2006年 | 5374篇 |
2005年 | 5459篇 |
2004年 | 5084篇 |
2003年 | 4529篇 |
2002年 | 4380篇 |
2001年 | 1048篇 |
2000年 | 895篇 |
1999年 | 1035篇 |
1998年 | 969篇 |
1997年 | 780篇 |
1996年 | 640篇 |
1995年 | 607篇 |
1994年 | 577篇 |
1993年 | 563篇 |
1992年 | 687篇 |
1991年 | 654篇 |
1990年 | 548篇 |
1989年 | 570篇 |
1988年 | 518篇 |
1987年 | 494篇 |
1986年 | 491篇 |
1985年 | 549篇 |
1984年 | 550篇 |
1983年 | 497篇 |
1982年 | 627篇 |
1981年 | 560篇 |
1980年 | 564篇 |
1979年 | 395篇 |
1978年 | 401篇 |
1977年 | 391篇 |
1976年 | 310篇 |
1975年 | 339篇 |
1974年 | 299篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
Catharine Chambers Shirley Chiu Allison N. Scott George Tolomiczenko Donald A. Redelmeier Wendy Levinson Stephen W. Hwang 《Community mental health journal》2014,50(5):553-559
The purpose of this study was to estimate the prevalence of mental health problems among a representative sample of homeless women with and without dependent children and determine if the effects of risk factors for mental health are modified by the presence of dependent children. Homeless women (n = 522) were recruited in 2004–2005 from shelters and meal programs in Toronto, Canada. Linear and logistic regression was performed to identify factors associated with mental health status. Poor mental health was associated with low perceived access to social support, physical/sexual assault in the past 12 months, presence of a chronic health condition, and presence of a drug use problem in the past month. Efforts to improve mental health in this population will need to address the associated problems of victimization, substance abuse, and lack of social supports. 相似文献
92.
Immunotherapeutic approaches involving genetic modification of T cells show promise in generating highly specific tumor-reactive effector cells for cancer treatment. Given the high affinity of FcRI (the subtype I Fc receptor for IgE) for IgE monoclonal antibody (mAb), modification of T cells with chimeric FcRI in combination with tumor-specific IgE mAbs is potentially a powerful and effective strategy to specifically target T cells to tumor cells. In this study, we retrovirally transduce human primary T cells with a cDNA encoding the extracellular domain of FcRI linked to the hinge and transmembrane domains of FcRI and the cytoplasmic domains of CD28 and T cell receptor zeta chain (FcRI-CD28-zeta). We demonstrate that human T cells expressing FcRI-CD28-zeta, in the presence of tumor-specific IgE mAb recognizing mouse CD8 antigen (Ly- 2.1+), can specifically secrete cytokine, proliferate, and mediate cytotoxic function after antigen ligation. Furthermore, adoptive transfer of FcRI-CD28-zeta cells incubated with anti-Ly-2.1 IgE mAb significantly enhances the survival of irradiated nonobese diabetic-severe combined immunodeficiency mice bearing Ly-2.1+ tumor compared with control mice. Thus, this set of experiments demonstrates that Fc gene-engineered human T cells mediate effector function in vitro and in vivo in an IgE-dependent manner and thus a novel and valid approach for cancer therapy can now be further developed. 相似文献
93.
Bas W.G. van Rhijn James W. Catto Peter J. Goebell Ruth Knüchel Shahrokh F. Shariat Henk G. van der Poel Marta Sanchez-Carbayo George N. Thalmann Bernd J. Schmitz-Dräger Lambertus A. Kiemeney 《Urologic oncology》2014,32(7):1078-1087
ObjectivesTo summarize the current status of clinicopathological and molecular markers for the prediction of recurrence or progression or both in non–muscle-invasive and survival in muscle-invasive urothelial bladder cancer, to address the reproducibility of pathology and molecular markers, and to provide directions toward implementation of molecular markers in future clinical decision making.Methods and materialsImmunohistochemistry, gene signatures, and FGFR3-based molecular grading were used as molecular examples focussing on prognostics and issues related to robustness of pathological and molecular assays.ResultsThe role of molecular markers to predict recurrence is limited, as clinical variables are currently more important. The prediction of progression and survival using molecular markers holds considerable promise. Despite a plethora of prognostic (clinical and molecular) marker studies, reproducibility of pathology and molecular assays has been understudied, and lack of reproducibility is probably the main reason that individual prediction of disease outcome is currently not reliable.ConclusionsMolecular markers are promising to predict progression and survival, but not recurrence. However, none of these are used in the daily clinical routine because of reproducibility issues. Future studies should focus on reproducibility of marker assessment and consistency of study results by incorporating scoring systems to reduce heterogeneity of reporting. This may ultimately lead to incorporation of molecular markers in clinical practice. 相似文献
94.
Kimon Bekelis Symeon Missios George Kakoulides Redi Rahmani Nathan Simmons 《The spine journal》2014,14(9):1944-1950
Background contextThere is a persistent trend for more outpatient lumbar discectomies in the United States.PurposeTo investigate the characteristics of the patients selected for ambulatory procedures.Study designRetrospective cohort study.Patient sampleForty-seven thousand one hundred twenty-five patients who underwent outpatient and 102,592 patients undergoing inpatient lumbar discectomies and were were registered in the State Ambulatory Surgery Database (SASD) and State Inpatient Database (SID), respectively, for New York, California, Florida, and North Carolina from 2005 to 2008.Outcome measuresRate of outpatient procedures, 30-day readmissions, and hospital charges.MethodsWe performed a retrospective cohort study involving patients who underwent outpatient and inpatient lumbar discectomies and were registered in SASD and SID, respectively, for New York, California, Florida, and North Carolina from 2005 to 2008. Logistic regression models were used to demonstrate the association of socioeconomic factors with the odds of undergoing an outpatient procedure.ResultsMale gender (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03–1.08), private insurance (OR, 1.93; 95% CI, 1.86–2.01), lower Charlson Comorbidity Index (OR, 4.04; 95% CI, 3.17–5.16), and higher volume hospitals (OR, 1.06; 95% CI, 1.04–1.08) were significantly associated with outpatient procedures. Higher income (OR, 0.83; 95% CI, 0.81–0.85), older age (OR, 0.996; 95% CI, 0.995–0.997), coverage by Medicaid (OR, 0.89; 95% CI, 0.83–0.96), African Americans (OR, 0.65; 95% CI, 0.60–0.70), and other minority races were associated with decreased odds of outpatient procedures. The rate of 30-day postoperative readmissions was higher among inpatients. Institutional charges were significantly lower for outpatient lumbar discectomies. The median charge for inpatient surgery was $24,273 as compared with $11,339 for the outpatient setting (p<.0001).ConclusionsAccess to ambulatory lumbar discectomies appears to be more common for younger, white, male patients, with private insurance and less comorbidities, in the setting of higher volume hospitals. Further investigation is needed in the direction of mapping these disparities for appropriate resource utilization. 相似文献
95.
Yichen Zhong Alvaro Mu?oz George J. Schwartz Bradley A. Warady Susan L. Furth Alison G. Abraham 《Journal of the American Society of Nephrology : JASN》2014,25(5):913-917
GFR decline in patients with CKD has been widely approximated using linear models, but this linearity assumption is not well validated. We conducted a matched case-control study in children from the Chronic Kidney Disease in Children (CKiD) cohort ages 1–16 years with mild to moderate CKD to assess whether GFR decline follows a nonlinear trajectory as CKD approaches ESRD. Children (n=125) who initiated RRT (cases) during follow-up were individually matched by CKD stage at baseline and glomerular/nonglomerular diagnosis with children (n=125) who remained RRT-free when the corresponding case initiated RRT (controls). GFR trajectories were compared using log-linear and piecewise log-linear mixed effects models adjusted for baseline characteristics. From study entry to 18 months before RRT, GFR declined 7% faster among cases compared with controls. However, GFR declined 26% faster among cases compared with controls (P<0.001) during the 18 months before RRT. Nonlinearity in the rate of kidney function loss, which was shown in this cohort, may preclude accurate clinical prediction of the timing of RRT and adequate patient preparation. This study should prompt the characterization of predictive factors that may contribute to an acceleration of kidney function decline.GFR is a key measurement of kidney function, and the degree of GFR decline over time is a reflection of the severity of CKD progression. GFR decline has been approximated as linear or log-linear in most analyses of progression, an assumption that has been consistent with available data.1–4 However, many studies rely on relatively short follow-up periods and few repeated measures. Given the convenience of assuming a linear GFR trajectory, which results from the ease of modeling and interpreting linear slopes, few studies have sought to validate the linearity assumption and explore the possibility of nonlinear GFR decline. However, nonlinearity in GFR decline has been observed in some epidemiologic studies,5–7 and the implications on the risk for adverse outcomes have generated interest.8 A CKD cohort study in France found that about one half of its patients experienced nonlinear GFR decline during the last year before dialysis.5 A study by Li et al.9 used a flexible approach to model nonlinearity in GFR trajectories. Li et al.9 found evidence of nonlinear GFR trajectory behavior in adult patients with CKD, and furthermore, the probability of having nonlinear features in an individual trajectory was associated with known risk factors for CKD progression. O’Hare et al.10 found several distinct nonlinear patterns of GFR decline in the 2 years before dialysis initiation in Veterans Affairs patients.Clinical strategies and subsequent patient response to care could potentially benefit from new insights into the variable paths of progression in patients with CKD.10,11 The question of whether characterizing the nonlinearity in the GFR trajectory can assist the identification of risk groups for outcomes, such as ESRD, remains unexplored. The implications on future outcomes of an increased rate of GFR decline could inform clinical decisions about screening frequencies, treatment, or preparation for RRT.The Chronic Kidney Disease in Children (CKiD) study is an ongoing cohort study of children with CKD who, at baseline, had an eGFR between 30 and 90 ml/min per 1.73 m3 and were ages 1–16 years. An end point of the study is RRT defined as transplant or dialysis. To determine whether trajectories of GFR accelerate before RRT, we nested a case-control study, in which cases were children observed to have received RRT and controls were children with CKD who remained RRT-free at the time when the corresponding case initiated RRT.There were 147 children who experienced RRT during follow-up. Each case was matched individually to an eligible control at the time of the case occurrence. The matching factors included baseline CKD stage, glomerular/nonglomerular diagnosis, and, through design, the amount of follow-up time from study entry. Matching was done without replacement, and 22 cases were excluded from the analyses, because no appropriate control was available. We used a random sequence to determine the order of matching. The analysis was, thus, based on 125 matched case-control pairs. Demographic and clinical characteristics of cases and controls at baseline are shown in Characteristics Cases (n=125) Controls (n=125) Age, yr 12.64 (9.23–14.53) 12.33 (8.71–14.74) Sex (girls), N (%) 38 (30.4) 57 (45.6) Race (nonwhite), N (%) 51 (40.8) 36 (28.8) Urine protein/creatinine ratio 1.74 (0.48–4.04) 0.60 (0.26–1.76) Proteinuria, N (%) 0.2≤protein/creatinine ratio<2 56 (46.7) 71 (59.7) Protein/creatinine ratio≥2 51 (42.5) 23 (19.3) Baseline GFRa 32.21 (26.43–39.64) 35.77 (27.86–43.78) Glomerular diagnosis, N (%)a 47 (37.6) 47 (37.6)